Therapeutic Asset Ratings
6,308 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Itnk Cell Therapy
Cancer
Second Affiliated Hospital of Guangzhou Medical University
P1/2
CCC
(48)
Itnk Cell Therapy
T-Cell And NK-Cell Neoplasm
Second Affiliated Hospital of Guangzhou Medical University
P1/2
CCC
(48)
Ivonescimab
Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CCC
(48)
Jab-21822
Appendix Cancer
Allist Pharmaceuticals, Inc.
P1/2
CCC
(48)
Jab-21822
Colorectal Cancer
Jian Li
P1/2
CCC
(48)
Jab-21822
Small Intestine Cancer
Allist Pharmaceuticals, Inc.
P1/2
CCC
(48)
Jab-2485
Small Cell Lung Carcinoma
Jacobio Pharmaceuticals Co., Ltd.
P1/2
CCC
(48)
Jab-2485
Triple-Negative Breast Carcinoma
Jacobio Pharmaceuticals Co., Ltd.
P1/2
CCC
(48)
jdb153
Pancreatic Adenocarcinoma
West China Hospital
P1/2
CCC
(48)
Jin-A02
Non-Small Cell Lung Carcinoma
J Ints Bio
P1/2
CCC
(48)
jk08
Breast Tumor Luminal A Or B
Salubris Biotherapeutics Inc
P1/2
CCC
(48)
jk08
Skin Squamous Cell Carcinoma
Salubris Biotherapeutics Inc
P1/2
CCC
(48)
Jskn003
Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
P1/2
CCC
(48)
Kamlanoflast
Neurodegenerative Disease
Inflammasome Therapeutics
P1/2
CCC
(48)
kb707
Lung Cancer
Krystal Biotech, Inc.
P1/2
CCC
(48)
kd6001
Hepatocellular Carcinoma
Shanghai Kanda Biotechnology Co., Ltd.
P1/2
CCC
(48)
Kite-363
B-Cell Non-Hodgkin Lymphoma
Kite, A Gilead Company
P1/2
CCC
(48)
Kite-753
B-Cell Non-Hodgkin Lymphoma
Kite, A Gilead Company
P1/2
CCC
(48)
kk8123
X-Linked Dominant Hypophosphatemic Rickets
Kyowa Kirin Co., Ltd.
P1/2
CCC
(48)
kl003 cell
Beta-Thalassemia Major
Kanglin Biotechnology (Hangzhou) Co., Ltd.
P1/2
CCC
(48)
KN510
Pancreatic Ductal Adenocarcinoma
New Cancer Cure-Bio Co.,Ltd.
P1/2
CCC
(48)
KN713
Pancreatic Ductal Adenocarcinoma
New Cancer Cure-Bio Co.,Ltd.
P1/2
CCC
(48)
Lacutoclax
Waldenstrom Macroglobulinemia
Guangzhou Lupeng Pharmaceutical Company LTD.
P1/2
CCC
(48)
Lamivudine
Refractory Malignant Neoplasm
Thomas Marron
P1/2
CCC
(48)
LENALIDOMIDE
Composite Lymphoma
M.D. Anderson Cancer Center
P1/2
CCC
(48)
Showing 1401 to 1425 of 6,308 assets
Previous
Page 57 of 253
Next